Skip to main content

Abeona Therapeutics Inc.

ABEO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000318306

In the last 90 days, Abeona Therapeutics Inc. insiders filed 0 open-market purchases and 7 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $243.3M in total; no superinvestor holds it.

13F holders, Q2 2023

Institutional positions in Abeona Therapeutics Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
37
+4 vs. Q1 2023
Shares held
9.39M
+1.87M (+24.8%) vs. Q1 2023
Total value
$37.9M
+$16.6M (+78.4%) vs. Q1 2023
New holders
9
8 more added
Sold out
5
8 more reduced

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ABEO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 37 institutions
Q1 2021: 78 institutionsQ2 2021: 73 institutionsQ3 2021: 60 institutionsQ4 2021: 53 institutionsQ1 2022: 56 institutionsQ2 2022: 44 institutionsQ3 2022: 25 institutionsQ4 2022: 41 institutionsQ1 2023: 33 institutionsQ2 2023: 37 institutionsQ3 2023: 40 institutionsQ4 2023: 48 institutionsQ1 2024: 56 institutionsQ2 2024: 48 institutionsQ3 2024: 55 institutionsQ4 2024: 65 institutionsQ1 2025: 71 institutionsQ2 2025: 95 institutionsQ3 2025: 100 institutionsQ4 2025: 104 institutionsQ1 2026: 108 institutionsQ2 2026: 126 institutions
Value heldQ2 2023: $37.9M
Q1 2021: $58.4MQ2 2021: $43.4MQ3 2021: $28.3MQ4 2021: $13.7MQ1 2022: $10.3MQ2 2022: $4.51MQ3 2022: $3.62MQ4 2022: $28.5MQ1 2023: $21.2MQ2 2023: $37.9MQ3 2023: $52.5MQ4 2023: $70.8MQ1 2024: $104.7MQ2 2024: $127.8MQ3 2024: $181.7MQ4 2024: $170.4MQ1 2025: $141.2MQ2 2025: $198.2MQ3 2025: $187.9MQ4 2025: $205.2MQ1 2026: $177.1MQ2 2026: $243.3M
Institutions holding ABEO and their total value by quarter
QuarterHoldersValue
Q2 2026126$243.3M
Q1 2026108$177.1M
Q4 2025104$205.2M
Q3 2025100$187.9M
Q2 202595$198.2M
Q1 202571$141.2M
Q4 202465$170.4M
Q3 202455$181.7M
Q2 202448$127.8M
Q1 202456$104.7M
Q4 202348$70.8M
Q3 202340$52.5M
Q2 202337$37.9M
Q1 202333$21.2M
Q4 202241$28.5M
Q3 202225$3.62M
Q2 202244$4.51M
Q1 202256$10.3M
Q4 202153$13.7M
Q3 202160$28.3M
Q2 202173$43.4M
Q1 202178$58.4M

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding Abeona Therapeutics Inc.; share changes are against Q1 2023.

Institutions holding ABEO in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Adage Capital Partners GP, L.L.C.1,761,160$7.10M0.02%+430,000+32.3%Added
Nantahala Capital Management, LLC1,401,880$5.65M0.69%−26,795−1.9%Reduced
Point72 Asset Management, L.P.1,131,423$4.56M0.02%−19,225−1.7%Reduced
Deerfield Management Company, L.P. (Series C)869,565$3.50M0.07%00.0%Unchanged
Millennium Management LLC692,971$2.79M0.00%+515,016+289.4%Added
Vanguard Group Inc669,603$2.70M0.00%+211,262+46.1%Added
AIGH Capital Management LLC638,974$2.58M1.05%−13,200−2.0%Reduced
J. Goldman & Co LP498,044$2.01M0.11%+498,044New
Western Standard LLC224,151$903.3K0.78%00.0%Unchanged
Goldman Sachs Group Inc213,282$859.5K0.00%+50,008+30.6%Added
Citigroup Inc200,000$806.0K0.00%+200,000New
Barclays PLC185,638$748.1K0.00%00.0%Unchanged
Knott David M Jr160,000$645.0K0.27%00.0%Unchanged
Worth Venture Partners, LLC159,311$642.0K0.35%−1,200−0.7%Reduced
Geode Capital Management, LLC157,593$635.1K0.00%−24,895−13.6%Reduced
BlackRock Inc.142,785$575.4K0.00%+87,057+156.2%Added
Northern Trust Corp103,235$416.0K0.00%+69,539+206.4%Added
State Street Corp51,095$205.9K0.00%+7,800+18.0%Added
Renaissance Technologies LLC33,537$135.0K0.00%−3,300−9.0%Reduced
Virtu Financial LLC32,171$130.0K0.01%+32,171New
Deutsche Bank AG16,022$64.6K0.00%00.0%Unchanged
CI Private Wealth, LLC13,902$56.0K0.00%+13,902New
Dimensional Fund Advisors LP12,991$52.4K0.00%00.0%Unchanged
Bank of New York Mellon Corp12,934$52.1K0.00%+12,934New
Morgan Stanley4,710$19.0K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.2,605$10.5K0.00%00.0%Unchanged
UBS Group AG1,105$4.45K0.00%+1,105New
Hartford Financial Management Inc.720$2.90K0.00%−27−3.6%Reduced
Simplex Trading, LLC710$2.00K0.00%+710New
Parallel Advisors, LLC400$1.61K0.00%00.0%Unchanged
Wells Fargo & Company128$5160.00%+15+13.3%Added
Rhumbline Advisers58$2330.00%+58New
Truvestments Capital LLC51$2060.00%00.0%Unchanged
FMR LLC16$640.00%+16New
JPMorgan Chase & Co14$560.00%−704−98.1%Reduced
Cambridge Trust Co13$520.00%00.0%Unchanged
25 LLC5$200.00%00.0%Unchanged
ExodusPoint Capital Management, LP0$00.00%−120,853−100.0%Sold out
Creative Planning0$00.00%−22,011−100.0%Sold out
Charles Schwab Investment Management Inc0$00.00%−18,000−100.0%Sold out
Phoenix Holdings Ltd.0$00.00%−11,874−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−640−100.0%Sold out